Cypress Bioscience News
Most Popular Cypress Bioscience Story
FDA approves new fibromyalgia drug
The FDA has approved Forest Laboratories and Cypress Bioscience's fibromyalgia drug Savella. Fibromyalgia is a chronic condition characterized by joint and muscle pain and decreased physical Read more...
Latest Headlines
- January 21, 2011
- December 15, 2010
- December 10, 2010
- September 28, 2010
- September 15, 2010
- August 26, 2010
- August 17, 2010
- August 12, 2010
- August 6, 2010
- August 4, 2010
- July 19, 2010
- January 15, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
